The AGC all-polyethylene tibial component: a ten-year clinical evaluation.
While high success rates have been achieved in association with other all-polyethylene tibial components, an alarming number of failures have occurred at our institution in association with the use of an all-polyethylene version of the AGC tibial component. The purpose of the present study was to describe the survival of the AGC all-polyethylene tibial component. Five hundred and thirty-six AGC all-polyethylene tibial components were implanted in 405 patients and were followed over a ten-year period. The average age of the patients at the time of surgery was 70.3 years, the average weight was 78 kg, and the most common diagnosis was osteoarthritis (prevalence, 92.9%). A clinical and radiographic analysis was performed, Knee Society knee and function scores were determined, and Kaplan-Meier survivorship analysis was conducted. Failure was defined as aseptic loosening as evidenced by progressive radiolucent lines and/or revision due to aseptic loosening or collapse. A high rate of failure was noted in the early postoperative period, with a survival rate of 90.04% (95% confidence interval, 87.35% to 92.72%) after three years. At ten years, the survival rate was 68.11% (95% confidence interval, 57.57% to 78.65%). Fifty-eight (73.4%) of seventy-nine failures occurred in association with loosening or collapse of the bone beneath the medial tibial plateau. While some all-polyethylene tibial designs have been successful, the low success rate among knees treated with the AGC all-polyethylene tibial component suggests that the results associated with all-polyethylene tibial components are design-sensitive. Therapeutic study, Level IV (case series [no, or historical, control group]). See Instructions to Authors for a complete description of levels of evidence.